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ABSTRACT
Objectives: The aim of this study was to establish the prevalence of cervicovaginal infections in
normal third-trimester pregnant women and evaluate the accuracy of clinical diagnosis.
Method: A total of 328 pregnant women were followed at the Prenatal Outpatient Clinic of the
Department of Obstetrics and Gynecology at the School of Medical Sciences, Universidade Es-
tadual de Campinas (UNICAMP), Brazil, from October 1991 to February 1993. The clinical
diagnosis was based on the characteristics of the vaginal discharge, and the etiological diagnosis was
based on bacterioscopy of the vaginal secretion and direct immunofluorescence for Chlamydia
trachomatis. The data were analyzed statistically, determining the sensitivity, specificity, and posi-
tive and negative predictive value of the clinical diagnosis related to the laboratory diagnosis of the
different infections.
Results: The prevalence of infection was 39.6% (Candida albicans, 19.2%; bacterial vaginosis,
9.5%; intermediate vaginal flora, 6.7%; Chlamydia trachomatis, 2.1%; and vaginal trichomoniasis,
2.1%). The accuracy of clinical diagnosis was low, with sensitivity between 50% and 65% and
specificity around 60%, with the exception of trichomoniasis, which showed a sensitivity of 100%
and chlamydia, with a sensitivity of 0% and a specificity of 100%.
Conclusion: The accuracy of the clinical diagnosis of infections was low, specifically with respect
to the positive predictive value. The results demonstrate the need for specific testing of cervicovagi-
nal infections at prenatal visits. Reliance on simple vaginal examination results in a low yield for
detection of vaginal infections. Infect. Dis. Obstet. Gynecol. 6:129-133, 1998.
(C) 1998 Wiley-Liss, Inc.
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n general, the presence of lower genital tract in-
fections poses a threat to the health of a woman.
When infection is present in the pregnant patient,
the consequences can be significant to the well-
being of the mother and fetus. Early detection is
important because maternal physiological alter-
ations may hamper the infections’ diagnosis and
management, and the presence of the fetus may
limit treatment.
Pregnancy offers an excellent opportunity to es-
tablish whether the vaginal ecosystem has been
altered or is infected. This, in turn, offers the phy-
sician an excellent opportunity for the investigation
and treatment of these infections and for education
of the patient.
The possible side effects of cervicovaginal in-
fections on the gestation of the fetus have been the
focus of several investigations for the past several
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years. Infections of the lower genital tract can have
a direct effect on the fetus, while others predispose
indirect fetal damage, secondary to premature labor
and/or premature rupture of membranes, z
In view of the frequent occurrence of lower
genital tract infections and their potential serious-
ness, self-medication continues to be very com-
mon. Individuals rely on a medication that was
used in the past or that was recommended by a
friend or by the salespersons at the pharmacy. Add-
ing to the problem, physicians commonly treat the
patient without even performing an examination.
Treatment is based on the patient’s description of
the symptoms, many times over the phone.
3
Another factor to consider in the management of
cervicovaginal infections is that they are frequently
asymptomatic. When they are symptomatic, their
clinical diagnosis is based only on the clinical char-
acteristics of the vaginal discharge, which has been
shown to be insufficient for establishing the correct
diagnosis in most cases.4
The literature is replete with studies document-
ing the prevalence of lower genital tract infections
during pregnancy. Risk factors such as race, socio-
economic level, STD background, and geographi-
cal localization appear to be significant,s The pre-
sent study was undertaken to determine the preva-
lence of lower genital tract infections among
pregnant women attending the obstetrical service
at the Hospital de Clfnicas of the Universidade
Estadual de Campinas, Brazil and to evaluate the
accuracy of the diagnosis based on the clinical im-
pression.
MATERIAL AND METHODS
A total of 328 women who were beginning their
third trimester of pregnancy and who voluntarily
agreed to participate were entered into the study.
All the patients attended the Pre-Natal Outpatient
Clinic of the Hospital de Clfnicas, at the Universi-
dade Estadual de Campinas (UNICAMP), Brazil,
in the period between October 28, 1991, and Feb-
ruary 16, 1993. Patients attending the High Risk
Pre-Natal Care Clinic were excluded. The research
protocol was submitted to and approved by the
institution’s Research and Ethical Committees.
Each woman went through a speculum exami-
nation, and the clinical characteristics of the vaginal
discharge were used to establish a clinical diagno-
sis, based only on the patient’s complaints and the
aspect of the vaginal discharge. Samples of the
vaginal discharge were collected and processed as
follows: pH measurement, Whiff test, wet mount
for light microscopy, and Gram stain. An endocer-
vical specimen was collected and subjected to di-
rect immunofluorescence antigen-antibody testing
for the detection of Chlamydia trachomatis (Kit
Patho DX-DPC, Diagnostic Products Corporation,
Los Angeles, CA). The results of these exams were
used to determine the definitive diagnosis of the
following infections: vaginal candidiasis (VC), bac-
terial vaginosis (BV), vaginal trichomoniasis (VT),
infection by Chlamydia trachomatis (CT), as well as
intermediate vaginal flora (IVF) without an etio-
logical agent.
6 The diagnosis of BV was based on
the presence of white vaginal discharge, positive
Whiff test, vaginal pH 4.5 and clue cells in the
Gram stain. 7
Data were analyzed through descriptive tables
of the variables studied, establishing the preva-
lence of the infections. The accuracy of the clinical
diagnosis was evaluated through frequency tables,
using the laboratory result as the gold standard.
The chi-square test or the exact Fischer test were
used for the statistical analysis, as appropriate.
RESULTS
The mean age was 25.7 years (SD 6.1), and 15.9%
were younger than 20 years of age. The mean num-
ber of gestations was 2.6 (SD 1.8), with more than
one third (38.7%) of the women being pregnant for
the first time. Sixty-three (19.2%) had a history of
one or more abortions, and over 10% did not have
a permanent live-in partner. One third of the pa-
tients were nonwhite, 27.1% were smokers, and
almost 70% had a low level of formal education.
Infection was diagnosed by clinical impression
in 139 women (42.4%): 17.2% intermediate vaginal
flora; 15.9% vaginal candidiasis; 6.2% vaginal
trichomoniasis and 3.1% bacterial vaginosis (Table
1). The presence of cervicovaginal infections was
established by specific laboratory testing in 121
women (36.9%), but 8 women had more than one
infection for a total of 130 (39.6%) positive tests.
The infection with the highest prevalence was
vaginal candidiasis (19.2%), followed by bacterial
vaginosis (9.5%) and intermediate vaginal flora
(6.7%). The other infections studied had much
lower prevalence: 2.1% for Chlamydia trachomatis
and for Trichomonas vaginalis (see Table 1).
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TABLE I. Prevalence of the different types of genital




Type of Infection N % N %
Candida albicans 52 15.9 63 19.2
Bacterial vaginosis 10 3. 31 9.5
Intermediate vaginal flora 56 17.2 22 6.7
Chlamydia trachomatis 07 2.
Trichomonas vaginalis 21 6.2 07 2.
TOTAL 139 42.4 130" 39.6
*8 women had more than one infection (121 women with at least one
laboratory infection)
Among the 139 patients with clinical diagnoses
of infection, only 74 (53.2%) were confirmed
through laboratory exams. On the other hand, 4.7
(24.9%) of the 189 patients clinically considered to
be without any infection had laboratory diagnoses
of cervicovaginal infections (Table 2).
The accuracy of the clinical diagnosis based only
on patient’s symptoms and the aspect of the vagi-
nal discharge at the speculum examination was low
regarding all the infections evaluated (Table 3).
Every infection was overdiagnosed by clinical im-
pression, with the exception of chlamydia, which
was never suspected. Every confirmed infection by
Trichomonas vaginalis was diagnosed by the clini-
cian, but the specificity was below 60%. The sen-
sitivity for all other infections was between 50%
and 65%, which, added to the low prevalence, led
to a very low positive predictive value, from 0 in
the case of Chlamydia to 29% for Candida. The
overdiagnosis and low prevalence expectedly coin-
cide with a high negative predictive value which
varied from 88% for Candida to 100% for Tricho-
monas vaginalis (Table 3).
DISCUSSION
The rate of vaginal infections observed in our study
may be considered high, as approximately 37% of
the pregnant women had at least one type of cer-
vicovaginal infection. This rate is similar to that
observed by other authors.8,9 The young age of
most women in the sample, a factor commonly as-
sociated with a higher frequency of such infections,
would allow one to expect even higher rates than
those observed.9
Vaginal candidiasis was the most prevalent in-
fection in this study, being present in practically
one-fifth of the women. This result agrees with the
literature, where it is described as the most fre-
quent genital infection during pregnancy, espe-
cially during the third trimester.9 Some studies, in-
cluding a few from Brazil, found a much higher
prevalence than the one observed in the present
study. 1,11 Probably one of the main factors that
may explain the difference in prevalence is the
methodology used for the diagnosis of vaginal can-
didiasis. The diagnostic method used in this study
was microscopic examination of unstained vaginal
discharge (wet preparation), the method most
readily accessible in our country. Besides, special-
ists in vaginal flora are convinced that many women
are asymptomatic carriers, while the simple pres-
ence of the yeast does not necessarily mean clinical
infection. 12
Our results demonstrated that the frequency of
the clinical diagnosis was quite similar to that of the
laboratory diagnosis (15.9% vs. 19.2%). However,
the expected coincidence between both diagnoses
did not occur, as less than 30% of the clinical di-
agnosis of vaginal candidiasis were confirmed by
the laboratory and less than two thirds of the cases
confirmed by the laboratory were diagnosed by
clinical examination.
Similarly, the very low sensitivity of the clinical
criteria for the diagnosis of BV confirms the need
for microscopy and Gram stain of vaginal discharge,
or at least pH measurement and Whiff test, as a
routine in antenatal care, considering the risks as-
sociated with BV during pregnancy.
On the other hand, vaginal trichomoniasis was
largely overdiagnosed by clinical impression, which
was confirmed by the laboratory in only one of
every three cases. The low prevalence found in this
study is shared by other studies9 and agrees with
the significant decrease in the prevalence of VT
observed in the last years.4 One of the explanations
for the low presence ofVT is the widespread use of
imidazolic derivatives for the treatment of any
frothy vaginal discharge. Since the clinical charac-
teristics of the discharge are nonspecific, VT can-
not be reliably diagnosed to permit treatment with-
out a demonstration of the presence of the organ-
isms.
The possibility that pregnancy per se increases
the risk of infection by C. trachomatis has been sug-
gested by various authors, particularly in studies
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Clinical Diagnosis N (%) N (%) Total
Women with cervicovaginal infection
Women without cervicovaginal infection
TOTAL
74 (61.2) 65 (31.4) 139
47 (38.8) 142 (68.6) 189
121 (36.9) 207 (63.1) 328
TABLE 3. Accuracy of the clinical diagnosis of cervicovaginal infections in 328 pregnantwomen (%)
Infection Prevalence Sensitiv. Specif. PPV PNV P <
At least one infection (I 2 I) 36.9 61.2 68.6 53.2 75. 0.000
Vaginal candidiasis (63) 19.2 63.5 62.5 28.8 87.8 0.001
Vaginal trichomoniasis (7) 2.1 100.0 58.7 5.0 100.0 0.01
Bacterial vaginosis (3 I) 9.5 64.5 59.8 14.4 94. 0.03
Intermediate vaginal flora (22) 6.7 50.0 58.0 7.9 94.1 NS
Chlamydia trachomatis (7) 2. 0 100.0 0 98.2 NS
number of subjects with the infection according to laboratory tests.
carried out with pregnant adolescents who have
higher rates of infection than nonpregnant teenag-
ers.1 Although this study included young women
(16% were adolescents), the prevalence ofCT was
very low (2.1%). In another study carried out by our
group in the same hospital, but among nonpreg-
nant women attending the family planning clinic,
the prevalence of CT was 6.7%, suggesting that at
least in our population, pregnancy is not associated
with increased risk of this infection. 13 On the other
hand, another explanation for a lower rate of Chla-
mydia trachomatis infection among pregnant women
may be that the assay is less sensitive in pregnant
women. The low proportion of unmarried women
or with a history ofSTD may also contribute to the
low rate observed in the sample.
The rate of CT infection found by us in preg-
nant women is similar to the rates found by other
authors 14,1s, although higher prevalence has also
been reported.9 The availability of a simpler, less
costly diagnostic method that could eventually be
used routinely would be of great help, but at pre-
sent, the low prevalence of maternal CT infection
found in this study does not justify its routine
search during prenatal care, considering the cost-
benefit of applying the current technology in our
country.
Besides the identification of these four groups of
infectious agents, a fifth group of pregnant women
who presented intermediate vaginal flora suggest-
ing some pathologic process were diagnosed, based
on the criteria of Hillier et al.6 The main finding
was a significant decrease of lactobacillus in the
microscopic examination of the vaginal discharge,
where bacterial vaginosis would be imminent. The
prevalence of this intermediate vaginal flora was
relatively high among the pregnant women studied
(6.7%).
It is recommended that pregnant women with
intermediate vaginal flora be carefully followed
during prenatal care, due to the higher risk of de-
veloping bacterial vaginosis and the higher risk of
its potential consequences. Repeated microscopic
examinations of the vaginal discharge should be
performed whenever the patient relates any symp-
toms.
The most important conclusion derived from
this study is that the clinician cannot trust his or her
impression of the symptoms and the aspect of the
vaginal discharge to make an etiological diagnosis
of cervicovaginal infection. The very low positive
predictive value of clinical diagnosis of specific in-
fections, ranging from 0 to 29%, indicated that if
instituted, the therapy would be useless in most
cases. Our results highlight the need to search ac-
tively for cervicovaginal infections during preg-
nancy, not limited to a single speculum examina-
tion. Low-cost and easy-to-carry-out clinical tests
(such as vaginal pH measure and Whiff test) and
laboratory exams (such as wet mount and Gram
stain) should become routine in prenatal care, due
to the relatively high prevalence of some infections
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and the association of some of them with perinatal
complications.
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